NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 20 filers reported holding NOVUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | – | 33 | +1550.0% | 0.00% | – |
| Q1 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 2 | -100.0% | 0.00% | – |
| Q2 2019 | $12,000 | -75.5% | 11,981 | -1.7% | 0.00% | – |
| Q1 2019 | $49,000 | – | 12,189 | +5676.8% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 211 | -95.0% | 0.00% | – |
| Q3 2018 | $20,000 | +25.0% | 4,219 | +83.4% | 0.00% | – |
| Q2 2018 | $16,000 | – | 2,300 | +6869.7% | 0.00% | – |
| Q3 2017 | $0 | – | 33 | -70.5% | 0.00% | – |
| Q2 2017 | $0 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 80,069 | $1,233,000 | 0.56% |